Archita Samir Patel – författare
Visar alla böcker från författaren Archita Samir Patel. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Inbunden, Engelska, 2024
2 216 kr
Skickas inom 10-15 vardagar
The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers.It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments.This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
E-bok
Engelska, 20242 933 kr
Läs direkt efter köp
The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers.
It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments.
This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
Häftad, Engelska, 2025
2 216 kr
Skickas inom 10-15 vardagar
The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers.It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments.This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.